SUBSCRIBE
SUBSCRIBE
News   Business

Ventrus Biosciences, Inc. Reports Second Quarter 2012 Financial Results

August 10, 2012 | 
1 min read

NEW YORK, Aug. 9, 2012 (GLOBE NEWSWIRE) -- Ventrus Biosciences, Inc. (Nasdaq:VTUS) today reported financial results for the second quarter ended June 30, 2012.

Earnings
MORE ON THIS TOPIC
Cigna Healthcare office in Delaware
Pharmacy benefit managers
Cigna Continues Biosimilar Push, Targets J&J’s Stelara With No Out-of-Pocket Cost
September 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Novartis' logo outside its building in S
Manufacturing
Novartis Starts Construction on Two US Sites to Bolster Radioligand Therapy Manufacturing
September 5, 2024
 · 
2 min read
 · 
Tristan Manalac
Business growth concept. Vector of a business man hand with pot watering profitable money tree
Business
ArsenalBio Snags Mega $325M Series C Round With Backing from Nvidia, Regeneron
September 4, 2024
 · 
1 min read
 · 
Annalee Armstrong
Pictured: Nasdaq headquarters in New York/iStock,
IPO
Lilly Partner BioAge Files for IPO to Advance Obesity Candidate
September 4, 2024
 · 
2 min read
 · 
Tristan Manalac